KIM&CHANG
Newsletter
A Quarterly Update of Korean IP Law & Policy
Fall 2017
PATENT
Original Drug Maker Obtains First Court Decision in Korea Finding Infringement of Patent for Second Medicinal Use
Pfizer successfully enforced its patent covering a secondary use of its Lyrica® product (active ingredient: pregabalin) against 13 generic drug manufacturers in Korea, and was awarded a total of about KRW 2.2 billion (approx. USD 2 million) in damages. Read more
Second Korean Supreme Court Decision Upholding Validity of a Selection Invention
The Korean Supreme Court recently upheld the validity of a selection invention patent owned by Merck, in the case Merck Patent GmbH and Sharp Corporation v. DIC Corporation. The term "selection invention" in Korea means an invention in which some or all of the constitutional elements are species of a genus concept disclosed in the prior art. Selection inventions are subject to very strict patentability requirements; even after the Korean Supreme Court provided detailed standards regarding the patentability of selection inventions in 2003, there were no cases in Korea upholding the patentability or validity of a selection invention for many years. Read more
Pharmaceutical Industry IP Practices in Korea Under Scrutiny Again by the KFTC
The Korean Fair Trade Commission (KFTC) recently conducted another intellectual property (IP) survey towards approximately 70 pharmaceutical companies (approximately 40 foreign and 30 domestic), seeking detailed information regarding their major products, patents, and litigation disputes involving IP in Korea. Read more
Patent Court Holds that Proof of "Exclusive Use" for Infringement Only Necessary if Other Uses Are First Shown to Exist
While there is no such thing as inducement of infringement under Korean patent law, Article 127(1) of the Korean Patent Act (KPA) provides that a party indirectly infringes a product patent by "producing, selling, leasing, importing or offering for selling or leasing a product that is exclusively used for the production of the patented product . . .," similar to contributory infringement law in the U.S. The key issue in Korean indirect infringement cases usually is whether "exclusive use" of the accused product for producing the patented product can be proven. Read more
Patent Court Holds Its First Ever Hearing in English
Substantial efforts are being made by the Korean Government to turn Korea into an Asian regional IP Hub. The most recent effort involves creating an International IP Hub Court, a specialized court panel within the Patent Court which will decide patent-related appeals in English. Read more
Income Tax Law Amended, Setting Clear Non-Tax Limits for Employee-Inventor Remuneration
The Income Tax Law and its Presidential Decree were amended on December 20, 2016 and February 3, 2017, respectively, to set clear guidelines for the tax treatment of employee-inventor remuneration and to define the scope of non-taxation. These amendments apply retroactively to any and all in-service invention remunerations paid beginning January 1, 2017. Read more
Changes to Patent Marking Rules
Unlike many other jurisdictions where patent marking plays a vital role in preserving a company's rights to recover money damages from an infringer, patent marking is not a requirement for damages in Korea. However, if you choose to mark products, only patent owners and licensees (exclusive or non-exclusive) can mark a product with the relevant patent numbers. Moreover, patent markings are only available for patents relating to (i) a product or (ii) a method of making a product. Read more
TRADEMARK & DESIGN
Working with Korean Customs: A Vital and Effective Way to Combat Counterfeiters
One of the first lines of defense in preventing the spread of counterfeit and imitation goods is to stop such goods from entering a country at the borders. Accordingly, intellectual property rights owners should always consider using Customs' services as a part of their enforcement programs in Korea. Read more
Amendments to the Design Protection Act
Several amendments to the Design Protection Act (DPA) went into effect on September 22, 2017. Read more
Korean Trademark Act's Guidelines for the Designation of Goods and Classification Recently Amended
One of the Trademark Act regulations, the Guidelines for the Designation of Goods and Classification ("Guidelines"), was amended on June 29, 2017, and the changes became effective on July 5, 2017. The Guidelines set out what designations of goods and services are acceptable to the Korean Intellectual Property Office (KIPO). Read more
FIRM NEWS
AWARDS & RANKINGS
Kim & Chang professionals named "IP Stars" by Managing Intellectual Property
29 Kim & Chang professionals recognized as Leading Practitioners in Asia, the Most Ever for a Korean Law Firm - Asialaw Leading Lawyers 2017
Kim & Chang professionals recognized by Who's Who Legal
Ann Nam-Yeon Kwon named to Euromoney's Women in Business Law
Kim & Chang named in IAM Patent 1000 - The World's Leading Patent Professionals
Man-Gi Paik named to IAM Strategy 300 - The World's Leading IP Strategists
EVENTS
The 25th IAKL Annual Conference in Seoul, September 14-17, 2017
The Global Series in London, September 25-26, 2017
AIPLA Annual Meeting in Washington, DC, October 19-21, 2017
EDITORS:
John J. KIM
Inchan Andrew KWON
PDF VIEW
German
Kim & Chang Jeongdong Building, 17F, 21-15 Jeongdong-gil, Jung-gu, Seoul 04518, Korea
Tel: +82-2-2122-3900    Fax: +82-2-2122-3800    Email: ip-group@kimchang.com    www.ip.kimchang.com
This e-mail service is provided for general informational purposes only and should not be considered a legal opinion of Kim & Chang nor relied upon in lieu of specific advice.
If you would like to UNSUBSCRIBE from this service, please click here.
If you have problems viewing this message, please click the following URL or enter it into your web browser:
http://www.kimchang.com/newsletter/2017newsletter/ip/eng/newsletter_ip_en_fall2017.html
This e-mail message and any attachments are intended for the exclusive use of the individual or entity named above and may constitute information that is privileged or confidential or otherwise protected from disclosure. Dissemination, distribution, forwarding or copying of this e-mail by anyone other than the intended recipient is prohibited. If you have received this e-mail in error, please notify us immediately by telephone or e-mail (ip-group@kimchang.com) and completely delete or destroy any and all electronic or other copies of the original message and any attachments.
© Kim & Chang 2017.